April 26, 2023
April 26, 2023 - Akorn Operating Company LLC has filed Chapter 7 bankruptcy on February 23, 2023. In
connection with that filing, the company has ceased
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global healthcare
April 26, 2023
April 26, 2023 - Seres Therapeutics, Inc. and Nestlé Health Science have announced the U.S. Food and
Drug Administration (FDA) approval of Vowst (fecal microbiota spores
April 25, 2023
April 25, 2023 - Biogen Inc. has announced that the U.S. Food and Drug Administration (FDA) has
approved Qalsody (tofersen) 100 mg/15mL injection for the treatment
April 17, 2023
April 17, 2023 - the FDA approved Gamida Cell’s Omisirge (omidubicel-onlv), a nicotinamide-modified
allogeneic cord blood–based hematopoietic progenitor cell therapy
April 17, 2023
April 17, 2023 - IntelGenx Corp. has announced that the U.S. Food and Drug Administration ("FDA") has
approved the Company’s RizaFilm ® VersaFilm ® 505(b)(2)
April 6, 2023
Ascend Laboratories LLC. is voluntarily recalling Dabigatran Etcxilate Capsules. USP 75 mg and 150 mg to
the consumer/user level due to the presence of a nitrosamine
April 6, 2023
April 6, 2023 - The U.S. Food and Drug Administration announced the final decision to withdraw
approval of Makena—a drug that had been approved under
April 5, 2023
April 5, 2023 - The U.S. Food and Drug Administration has issued a draft guidance, "Patient-Focused Drug
Development: Incorporating Clinical Outcome Assessments